Watch for the S-3 effectiveness and the second tranche disbursement (~Oct 21-23, 2026). Monitor the Nov 10, 2026 annual meeting for stockholder vote on lifting the Exchange Cap — if approved, Yorkville could receive up to 34.2M shares, massively diluting existing holders. Track Yorkville's resale activity post-effectiveness; any large volume sales would pressure the stock price. The company's financial position (not provided in this filing) will determine whether this is a desperation raise or opportunistic — check the next 10-Q for cash runway.
Price Chart
Executive Summary
Health In Tech filed Amendment No. 1 to its S-3 shelf registration to register up to 34,224,247 shares of Class A common stock for resale by Yorkville (YA II PN, LTD) under an existing Standby Equity Purchase Agreement (SEPA). The shares consist of up to 9,532,889 Conversion Shares from convertible notes and up to 24,691,358 Advance Shares representing up to $20 million in potential gross proceeds. The company will not receive proceeds from Yorkville's resales but may receive up to $34.25 million from future note sales and stock advances, though all advance proceeds are currently locked into repaying the convertible notes. The filing is a routine step to enable the SEPA mechanism, but the massive potential dilution (up to 39% of outstanding shares) and the company's reliance on Yorkville for funding are bearish signals.
Key Facts
- Registers up to 34,224,247 shares for resale by Yorkville under the SEPA dated August 12, 2026.
- Shares include up to 9,532,889 Conversion Shares (convertible notes at $1.5735/share) and up to 24,691,358 Advance Shares (at 97% of lowest VWAP).
- As of October 6, 2026, there were 53,600,790 shares outstanding; the registered shares represent ~39% of outstanding and ~62.3% of non-affiliate float.
- Yorkville already holds 2,815,156 shares (4.99% beneficial ownership) and can increase the conversion ownership limit to 9.99% with 65 days' notice.
- First convertible note of $7 million (net $6.65M after 5% discount) was issued on August 18, 2026; second $3M note due on later of Oct 21, 2026 or 2 days after S-3 effectiveness.
- All proceeds from advance share sales must repay convertible notes until those notes are fully repaid, unless Yorkville agrees otherwise.
- Exchange cap of 13,100,378 shares (19.99% of pre-SEPA outstanding) limits issuances unless stockholder approval is obtained at the Nov 10, 2026 annual meeting.
- Yorkville is an 'underwriter' under the Securities Act and may sell shares via various methods including at-the-market, block trades, and negotiated transactions.
- The company paid Yorkville a $25,000 structuring fee and a $200,000 commitment fee (1% of $20M commitment).
- Independent Investment Bankers Corp. will receive a 6.5% success fee on each prepaid advance tranche.
Financial Impact
Potential dilution of up to 39% of outstanding shares (34.2M new shares vs 53.6M existing). Maximum gross proceeds to company of $34.25M ($15M from convertible notes + $20M from advances), but all advance proceeds are currently trapped to repay notes.
Risk Factors
- Massive dilution: 34.2M new shares represent ~39% of current outstanding, potentially depressing stock price.
- Yorkville can sell shares at a 3% discount to VWAP, creating constant downward pressure as it monetizes positions.
- All advance proceeds are locked into repaying convertible notes — no new operating cash until notes are fully repaid.
- If stockholder approval for the Exchange Cap is not obtained, only 13.1M shares can be issued, limiting the funding available.
- The company is an emerging growth company and smaller reporting company with reduced disclosure requirements, increasing information risk.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001213900-26-108612 |
| Document: ea030830801ex-fee.htm | 0001213900-26-108612 |
| Document: ea030830801ex5-1.htm | 0001213900-26-108612 |
| Document: ea030830801ex23-2.htm | 0001213900-26-108612 |
| Document: 0001213900-26-108612-index-headers.html | 0001213900-26-108612 |
| Document: 0001213900-26-108612-index.html | 0001213900-26-108612 |
| Document: 0001213900-26-108612.txt | 0001213900-26-108612 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 3 | $0.5753 | awaiting T+60 | — | $0.5005 (−13.00%) |
Oct 16, 2026 9d ago | 8-K | $0.6350 | awaiting T+60 | — | $0.5005 (+21.18%) |
Oct 16, 2026 10d ago | EFFECT | $0.6520 | awaiting T+60 | — | $0.5005 (+23.24%) |
Oct 13, 2026 13d ago | DEF 14A | $0.6780 | awaiting T+60 | — | $0.5005 (+26.18%) |
Oct 9, 2026 16d ago | S-3/A | $0.7200 | awaiting T+60 | — | $0.5005 (+30.49%) |
Sep 30, 2026 25d ago | Press Release | $0.7380 | awaiting T+60 | — | $0.5005 (−32.18%) |
Sep 29, 2026 27d ago | SC 13G | $0.8525 | awaiting T+60 | — | $0.5005 (−41.29%) |
Sep 4, 2026 7w ago | S-3 | $0.9801 | awaiting T+60 | — | $0.5005 (+48.93%) |
Aug 13, 2026 10w ago | Press Release | $1.01 | awaiting T+60 | — | $0.5005 (+50.20%) |
Jun 26, 2026 17w ago | S-3/A | $1.01 $0.8466 | ▲ +16.18% | ▲ +20.56% | $0.5005 (+50.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers